273 related articles for article (PubMed ID: 30509601)
1. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.
Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK
J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
Aqul A; Jonas MM; Harney S; Raza R; Sawicki GS; Mitchell PD; Fawaz R
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):505-511. PubMed ID: 27782957
[TBL] [Abstract][Full Text] [Related]
3. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
Dana J; Girard M; Franchi-Abella S; Berteloot L; Benoit-Cherifi M; Imbert-Bismut F; Sermet-Gaudelus I; Debray D
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101855. PubMed ID: 34933150
[TBL] [Abstract][Full Text] [Related]
5. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
Lewindon PJ; Puertolas-Lopez MV; Ramm LE; Noble C; Pereira TN; Wixey JA; Hartel GF; Calvopina DA; Leung DH; Ramm GA
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
9. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
Leung DH; Ye W; Schwarzenberg SJ; Freeman AJ; Palermo JJ; Weymann A; Alonso EM; Karnsakul WW; Murray KF; Stoll JM; Huang S; Karmazyn B; Masand P; Magee JC; Alazraki AL; Towbin AJ; Nicholas JL; Green N; Otto RK; Siegel MJ; Ling SC; Navarro OM; Harned RK; Narkewicz MR; Molleston JP;
J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP
Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
[TBL] [Abstract][Full Text] [Related]
12. Extended Screening for Cystic Fibrosis-related Liver Disease Including Elastography in Children and Adolescents.
Højte C; Jørgensen MH; Jensen F; Katzenstein TL; Skov M
J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):663-668. PubMed ID: 33093375
[TBL] [Abstract][Full Text] [Related]
13. The impact of hepatic steatosis on portal hypertension.
Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T
PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the characterization of hepatic tissue strain in children with cystic-fibrosis-associated liver disease (CFLD) by acoustic radiation force impulse imaging.
Behrens CB; Langholz JH; Eiler J; Jenewein R; Naehrlich L; Fuchs K; Harth S; Krombach GA; Alzen GF
Pediatr Radiol; 2013 Mar; 43(5):552-7. PubMed ID: 23192669
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
[TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
[TBL] [Abstract][Full Text] [Related]
19. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
[TBL] [Abstract][Full Text] [Related]
20. The natural history of cystic fibrosis liver disease a prospective cohort study.
Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
